Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boroujerdi

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Research Communications in Chemical Pathology and Pharmacology|September 1, 1986
A nonlinear tissue-binding model for creatine: estimation of creatine turnover time and creatinine production rateM Boroujerdi
The Journal of Pharmacy and Pharmacology|December 1, 1996
Pharmacokinetic-toxicodynamic relationships of adriamycin in rat: prediction of butylated hydroxyanisole-mediated reduction in anthracycline cardiotoxicityJ Vora, M Boroujerdi
Cancer Chemotherapy and Pharmacology|September 6, 2000
Interaction of dexrazoxane with red blood cells and hemoglobin alters pharmacokinetics of doxorubicinS Vaidyanathan, M Boroujerdi
The Journal of Pharmacy and Pharmacology|January 13, 2000
Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in ratsK Behnia, M Boroujerdi
Cancer Chemotherapy and Pharmacology|October 6, 2000
Effect of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity of doxorubicin in female ratsS Vaidyanathan, M Boroujerdi
Cancer Chemotherapy and Pharmacology|April 2, 1998
Investigation of the enterohepatic recirculation of Adriamycin and its metabolites by a linked-rat modelK Behnia, M Boroujerdi
Research Communications in Chemical Pathology and Pharmacology|June 1, 1987
BHA (2(3)-tert-butyl-4-hydroxyanisole)-mediated modulation of acetaminophen phase II metabolism in vivo in Fisher 344 ratsW J McLaughlin, M Boroujerdi
The Journal of Pharmacy and Pharmacology|August 2, 2001
Contradistinction between doxorubicin and epirubicin: in-vivo metabolism, pharmacokinetics and toxicodynamics after single- and multiple-dosing in ratsS Ramanathan-Girish, M Boroujerdi
Research Communications in Chemical Pathology and Pharmacology|March 1, 1988
Effect of cimetidine on in vivo formation of adducts between metabolites of benzo(a)pyrene and DNAM Y Choong, M Boroujerdi
The Journal of Pharmacy and Pharmacology|June 29, 2001
Contradistinction between doxorubicin and epirubicin: in-vitro interaction with blood componentsS Ramanathan-Girish, M Boroujerdi
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Research Communications in Chemical Pathology and Pharmacology|September 1, 1986
A nonlinear tissue-binding model for creatine: estimation of creatine turnover time and creatinine production rateM Boroujerdi
The Journal of Pharmacy and Pharmacology|December 1, 1996
Pharmacokinetic-toxicodynamic relationships of adriamycin in rat: prediction of butylated hydroxyanisole-mediated reduction in anthracycline cardiotoxicityJ Vora, M Boroujerdi
Cancer Chemotherapy and Pharmacology|September 6, 2000
Interaction of dexrazoxane with red blood cells and hemoglobin alters pharmacokinetics of doxorubicinS Vaidyanathan, M Boroujerdi
The Journal of Pharmacy and Pharmacology|January 13, 2000
Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in ratsK Behnia, M Boroujerdi
Cancer Chemotherapy and Pharmacology|October 6, 2000
Effect of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity of doxorubicin in female ratsS Vaidyanathan, M Boroujerdi
Cancer Chemotherapy and Pharmacology|April 2, 1998
Investigation of the enterohepatic recirculation of Adriamycin and its metabolites by a linked-rat modelK Behnia, M Boroujerdi
Research Communications in Chemical Pathology and Pharmacology|June 1, 1987
BHA (2(3)-tert-butyl-4-hydroxyanisole)-mediated modulation of acetaminophen phase II metabolism in vivo in Fisher 344 ratsW J McLaughlin, M Boroujerdi
The Journal of Pharmacy and Pharmacology|August 2, 2001
Contradistinction between doxorubicin and epirubicin: in-vivo metabolism, pharmacokinetics and toxicodynamics after single- and multiple-dosing in ratsS Ramanathan-Girish, M Boroujerdi
Research Communications in Chemical Pathology and Pharmacology|March 1, 1988
Effect of cimetidine on in vivo formation of adducts between metabolites of benzo(a)pyrene and DNAM Y Choong, M Boroujerdi
The Journal of Pharmacy and Pharmacology|June 29, 2001
Contradistinction between doxorubicin and epirubicin: in-vitro interaction with blood componentsS Ramanathan-Girish, M Boroujerdi
Pageof 3